Patents

Company seeks patent on large-scale manufacturing process for high-purity DNA

Published in Biotech Business Week, January 10th, 2005

CytoGenix, Inc., (CYGX) announced the filing of a patent application with the U.S. Patent and Trademark Office for an invention titled "Chemo-Enzymatic Synthesis of DNA and Uses Thereof."

This new technology is a significant advance and a big step towards making DNA medicines a reality, according to the company.

Currently, manufacturers use large fermentation vats of cloned E. coli bacteria to produce DNA by culturing, then rupturing the bacteria to extract the DNA. This process produces great quantities of toxic bacterial contaminants. Sophisticated and expensive purification methods are necessary to remove these toxins, driving the cost of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2005-01-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry